Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-23
2008-11-11
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S274100
Reexamination Certificate
active
07449484
ABSTRACT:
The present invention is directed to novel compounds of Formula (I) for use in the treatment of diseases in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.
REFERENCES:
patent: 3707475 (1972-12-01), Lambardino
patent: 3940486 (1976-02-01), Fitzi
patent: 5656644 (1997-08-01), Adams et al.
patent: WO-99061437 (1999-12-01), None
patent: WO-0137835 (2001-05-01), None
patent: WO-0224680 (2002-03-01), None
Revesz et al.; SAR of 4-hydrozyalkyl substituted heterocycles as novel p38 Map kinase inhibitors; Bioorganic & Medicinal Chemistry Letters; 2000; 1/11; 1261-1264.
Adams Jerry L.
Bryan Deborah L.
Lemanowicz John L.
Morris Patricia L
SmithKline Beecham Corporation
LandOfFree
Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4023752